RT Journal Article
SR Electronic
T1 First-in-human phase I/Ib study of NIZ985, a recombinant heterodimer of IL-15 and IL-15Rα, as a single agent and in combination with spartalizumab in patients with advanced and metastatic solid tumors
JF Journal for ImmunoTherapy of Cancer
JO J Immunother Cancer
FD BMJ Publishing Group Ltd
SP e007725
DO 10.1136/jitc-2023-007725
VO 11
IS 10
A1 Leidner, Rom
A1 Conlon, Kevin
A1 McNeel, Douglas G
A1 Wang-Gillam, Andrea
A1 Gupta, Sumati
A1 Wesolowski, Robert
A1 Chaudhari, Monica
A1 Hassounah, Nadia
A1 Lee, Jong Bong
A1 Ho Lee, Lang
A1 O’Keeffe, Jessica A
A1 Lewis, Nancy
A1 Pavlakis, George N
A1 Thompson, John A
YR 2023
UL http://jitc.bmj.com/content/11/10/e007725.abstract
AB Markup server — Error Not Found The page you were trying to reach could not be found. Please check the address for the page you were trying to reach. If you believe you have reached this page in error, you may contact us with any questions.